BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang YX, Wu WJ, Zhang YZ, Feng YL, Zhou XX, Pan Q. Noninvasive assessment of liver fibrosis with combined serum aminotransferase/platelet ratio index and hyaluronic acid in patients with chronic hepatitis B. World J Gastroenterol 2008; 14(46): 7117-7121 [PMID: 19084920 DOI: 10.3748/wjg.14.7117]
URL: https://www.wjgnet.com/1007-9327/full/v14/i46/7117.htm
Number Citing Articles
1
Erkin Oztas, Ufuk Baris Kuzu, Neslihan Inci Zengin, Ismail Hakki Kalkan, Fatih Saygili, Hakan Yildiz, Huseyin Tugrul Celik, Meral Akdogan, Mesut Yalin Kilic, Aydin Seref Koksal, Bulent Odemis, Nuretdin Suna, Ertugrul Kayacetin. Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?Medicine 2015; 94(47): e1889 doi: 10.1097/MD.0000000000001889
2
Da-Wu Zeng, Jing Dong, Jia-Ji Jiang, Yue-Yong Zhu, Yu-Rui Liu. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferaseWorld Journal of Gastroenterology 2016; 22(43): 9586-9594 doi: 10.3748/wjg.v22.i43.9586
3
Hui Zhang, Jianchun Xian, Yang Li, Li Xiao, Lu Wang, Muhammad Zia-Ul-Haq. Effects of Tenofovir Combined with Recombinant Human Interferon α-2b on Negative Conversion Rate, Liver Function, Immune Status, and Drug Safety in Patients with Chronic Hepatitis B: A Systematic Review and Meta-AnalysisEvidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/1889628
4
Keyur Patel, Sumeet K. Asrani, Maria Isabel Fiel, Deborah Levine, Daniel H. Leung, Andres Duarte-Rojo, Jonathan A. Dranoff, Tarek Nayfeh, Bashar Hasan, Tamar H. Taddei, Yahya Alsawaf, Samer Saadi, Abdul Mounaem Majzoub, Apostolos Manolopoulos, Muayad Alzuabi, Jingyi Ding, Nigar Sofiyeva, Mohammad H. Murad, Mouaz Alsawas, Don C. Rockey, Richard K. Sterling. Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice GuidelineHepatology 2024;  doi: 10.1097/HEP.0000000000000842
5
Danan Wang, Qinghui Wang, Fengping Shan, Beixing Liu, Changlong Lu. Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markersBMC Infectious Diseases 2010; 10(1) doi: 10.1186/1471-2334-10-251
6
Wenwen Jin, Zhonghua Lin, Yongning Xin, Xiangjun Jiang, Quanjiang Dong, Shiying Xuan. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysisBMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-14
7
Giada Sebastiani. Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithmsWorld Journal of Gastroenterology 2009; 15(18): 2190-2203 doi: 10.3748/wjg.15.2190
8
Tarek A Besheer, Mahmoud M El-Bendary, Khaled R Zalata, Hossam E Zaghalol. Evaluation of Fibrosis Progression by Noninvasive Biochemical Markers in Egyptian Patients with Chronic Hepatitis BEuroasian Journal of Hepato-Gastroenterology 2011; 1(2): 71 doi: 10.5005/jp-journals-10018-1016
9
Da-Wu Zeng, Jing Dong, Yu-Rui Liu, Jia-Ji Jiang, Yue-Yong Zhu. Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infectionWorld Journal of Gastroenterology 2016; 22(29): 6663-6672 doi: 10.3748/wjg.v22.i29.6663
10
A.S.F. Lok. Hepatitis B: Liver fibrosis and hepatocellular carcinomaGastroentérologie Clinique et Biologique 2009; 33(10-11): 911 doi: 10.1016/j.gcb.2009.06.001
11
Sahar Rostami, Hadi Parsian. Hyaluronic Acid: From Biochemical Characteristics to its Clinical Translation in Assessment of Liver FibrosisHepatitis Monthly 2013; 13(12) doi: 10.5812/hepatmon.13787
12
Olga H. Orasan, Mihaela Iancu, Madalina Sava, Aniela Saplontai‐Pop, Angela Cozma, Simina Tarmure Sarlea, Corneliu Lungoci, Marius‐Ionut Ungureanu, Vasile Negrean, Dorel Sampelean, Dan Lucian Dumitrascu. Non‐invasive assessment of liver fibrosis in chronic viral hepatitisEuropean Journal of Clinical Investigation 2015; 45(12): 1243 doi: 10.1111/eci.12543
13
Susanne Beckebaum, Speranta Iacob, Christian G. Klein, Alexander Dechêne, Joye Varghese, Hideo A. Baba, Georgios C. Sotiropoulos, Andreas Paul, Guido Gerken, Vito R. Cicinnati. Assessment of Allograft Fibrosis by Transient Elastography and Noninvasive Biomarker Scoring Systems in Liver Transplant PatientsTransplantation 2010; 89(8): 983 doi: 10.1097/TP.0b013e3181cc66ca
14
S. Harkisoen, J. E. Arends, A. van den Hoek, K. J. van Erpecum, G. J. Boland, A. I. M. Hoepelman. Low serum hyaluronic acid levels associated with spontaneous HBsAg clearanceEuropean Journal of Clinical Microbiology & Infectious Diseases 2015; 34(11): 2183 doi: 10.1007/s10096-015-2467-x
15
Jia-Zhen Zhang, Jing-Jing Cai, Yao Yu, Zhi-Gang She, Hongliang Li. Nonalcoholic Fatty Liver Disease: An Update on the DiagnosisGene Expression 2019; 19(3): 187 doi: 10.3727/105221619X15553433838609
16
Hong-Bo Liu, Jian-Ping Zhou, Yong Zhang, Xiao-Hui Lv, Wei Wang. Prediction on liver fibrosis using different APRI thresholds when patient age is a categorical marker in patients with chronic hepatitis BClinica Chimica Acta 2011; 412(1-2): 33 doi: 10.1016/j.cca.2010.08.032
17
Hiroki Nishikawa, Hirayuki Enomoto, Kazunori Yoh, Yoshinori Iwata, Kunihiro Hasegawa, Chikage Nakano, Ryo Takata, Kyohei Kishino, Yoshihiro Shimono, Yoshiyuki Sakai, Takashi Nishimura, Nobuhiro Aizawa, Naoto Ikeda, Tomoyuki Takashima, Akio Ishii, Hiroko Iijima, Shuhei Nishiguchi. Serum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis CMedicine 2016; 95(24): e3920 doi: 10.1097/MD.0000000000003920
18
Giada Sebastiani, Konstantinos Gkouvatsos, Mario Plebani. Non-invasive assessment of liver fibrosis: it is time for laboratory medicinecclm 2011; 49(1): 13 doi: 10.1515/CCLM.2011.001
19
JianPing Wu, WeiLin Mao. Review of Serum Biomarkers and Models Derived from Them in HBV-Related Liver DiseasesDisease Markers 2020; 2020: 1 doi: 10.1155/2020/2471252
20
Madiha M. El-Attar, Hebat-Allah G. Rashed, Eman M. Sewify, Howayda E. Hassan. A suggested algorithm for using serum biomarkers for the diagnosis of liver fibrosis in chronic hepatitis C infectionArab Journal of Gastroenterology 2010; 11(4): 206 doi: 10.1016/j.ajg.2010.09.005
21
Simin Dokht Shoaei, Shahnaz Sali, Mehdi Karamipour, Esmail Riahi. Non-Invasive Histologic Markers of Liver Disease in Patients With Chronic Hepatitis BHepatitis Monthly 2014; 14(2) doi: 10.5812/hepatmon.14228
22
Catriona Crossan, Emmanuel A Tsochatzis, Louise Longworth, Kurinchi Gurusamy, Brian Davidson, Manuel Rodríguez-Perálvarez, Konstantinos Mantzoukis, Julia O’Brien, Evangelos Thalassinos, Vassilios Papastergiou, Andrew Burroughs. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluationHealth Technology Assessment 2015; 19(9): 1 doi: 10.3310/hta19090
23
Speranta Iacob, Vito Cicinnati, Iyad Kabar, Anna Hüsing-Kabar, Arnold Radtke, Razvan Iacob, Hideo Baba, Hartmut H. Schmidt, Andreas Paul, Susanne Beckebaum. Prediction of late allograft dysfunction following liver transplantation by immunological blood biomarkersTransplant Immunology 2021; 69: 101448 doi: 10.1016/j.trim.2021.101448
24
Guangqin Xiao, Jiayin Yang, Lunan Yan. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis‐4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: A systemic review and meta‐analysisHepatology 2015; 61(1): 292 doi: 10.1002/hep.27382